Your shopping cart is currently empty

15-keto-Prostaglandin E2 is an endogenous bioactive metabolite that inhibits STAT3 activation through covalent interaction with the Cys259 residue, while also binding to and stabilizing EP2 and EP4 receptors, thereby exerting inhibitory effects on breast cancer cell growth and tumor progression, activating PPAR-γ signaling, and promoting fungal growth, collectively positioning this lipid mediator as a multifunctional regulator in cancer biology, immunometabolism, and host–pathogen interaction research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 500 μg | $123 | - | In Stock | |
| 1 mg | $218 | - | In Stock | |
| 5 mg | $543 | - | In Stock | |
| 10 mg | $773 | - | In Stock | |
| 25 mg | $1,160 | - | In Stock | |
| 50 mg | $1,560 | - | In Stock | |
| 100 mg | $2,090 | - | In Stock |
| Description | 15-keto-Prostaglandin E2 is an endogenous bioactive metabolite that inhibits STAT3 activation through covalent interaction with the Cys259 residue, while also binding to and stabilizing EP2 and EP4 receptors, thereby exerting inhibitory effects on breast cancer cell growth and tumor progression, activating PPAR-γ signaling, and promoting fungal growth, collectively positioning this lipid mediator as a multifunctional regulator in cancer biology, immunometabolism, and host–pathogen interaction research. |
| In vivo | In a mouse xenograft model using MDA-MB-231 cells, intraperitoneal (i.p.) injection of 15-keto-Prostaglandin E2 suppressed tumor growth, resulting in reduced tumor volume and weight. This reduction correlates with the downregulation of p-STAT3 and Cyclin D1 levels in the tumor tissues [1]. |
| Synonyms | 15-keto-PGE2 |
| Molecular Weight | 350.45 |
| Formula | C20H30O5 |
| Cas No. | 26441-05-4 |
| Smiles | C(/C=C\CCCC(O)=O)[C@@H]1[C@@H](/C=C/C(CCCCC)=O)[C@H](O)CC1=O |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (228.28 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.